4//SEC Filing
Bogle Grant C. 4
Accession 0000899243-21-033401
CIK 0001571498other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:02 AM ET
Size
7.6 KB
Accession
0000899243-21-033401
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Bogle Grant C.
Director
Transactions
- Award
Common Stock, par value $0.0001
2021-08-16+87,500→ 95,560 total - Award
Stock Option (Right to Buy)
2021-08-16+417,500→ 417,500 totalExercise: $5.31Exp: 2031-08-15→ Common Stock (417,500 underlying)
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 87,500 restricted stock units ("RSUs") granted pursuant to the Company's 2013 Stock Incentive Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in three equal annual installments over three years from the grant date, with the first installment vesting on August 16, 2022.
- [F2]This option was granted on August 16, 2021 pursuant to the Company's 2013 Stock Incentive Plan with respect to 417,500 shares of Common Stock, with 33.33% vesting on August 16, 2022 and the remaining 66.67% vesting in 24 substantially equal monthly installments thereafter.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeother
Related Parties
1- filerCIK 0001646675
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:02 AM ET
- Size
- 7.6 KB